A Study of GC203 TIL in Advanced Malignant Solid Tumors

NCT06375187 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor
Gynecologic Cancer
Breast Cancer
Gastrointestinal Cancer
Lung Cancer

Interventions

BIOLOGICAL: Engineering Tumor Infiltrating Lymphocytes

Sponsor

Shanghai Juncell Therapeutics